Table 4 Comparison of clinical characteristics between the two groups

Male(number, %)

20(70)

6(75)

0.109

0.741

Age (years,‾x ± s)

50.00 ± 11.33

53.63 ± 10.25

0.816

0.420

Hypertension(number, %)

26(89.66)

3(37.5)

10.065

0.002

Tobacco smoking(number, %)

6(20.69)

1(12.5)

0.274

0.601

Alcohol drinking(number, %)

5(17.24)

1(12.5)

0.104

0.747

DR(number, %)

14(48.28)

1(12.5)

3.329

0.068

BMI (kg/m2, ‾x ± s)

25.13 ± 3.64

25.35 ± 3.63

0.154

0.879

SBP(mmHg, ‾x ± s)

155.66 ± 19.89

135.00 ± 17.12

-2.670

0.011

DBP (mmHg, ‾x ± s)

91.14 ± 11.38

82.88 ± 10.56

-1.844

0.074

Diabetes duration[month, M (Q1, Q3)]

66(24,120)

12(1,42)

-1.439

0.150

HbA1C [%, M (Q1, Q3)]

7.95(6.60,10.70)

7.30(6.85,7.70)

-0.343

0.732

Hb [g/L, M (Q1, Q3)]

116(99,133)

153(137,157)

-2.823

0.005

FPG [mmol/L, M (Q1, Q3)]

7.00(5.95,9.71)

7.36(6.71,7.66)

-0.664

0.507

ALB(g/L,‾x ± s)

31.93 ± 8.89

29.59 ± 6.93

-0.688

0.496

TC (mmol/L,‾x ± s)

6.42 ± 2.02

7.23 ± 1.46

1.052

0.300

HDL-C [mmol/L, M (Q1, Q3)]

1.13(0.83,1.44)

1.10(0.98,1.12)

-0.572

0.56

LDL-C (mmol/L,‾x ± s)

4.32 ± 1.67

4.54 ± 1.58

0.332

0.742

Scr [umol/L, M(Q1,Q3)]

88(70,117)

75(67,76.5)

-2.492

0.013

UA (umol/L, ‾x ± s)

371.17 ± 78.46

328.13 ± 93.77

-1.319

0.196

eGFR(ml/min /1.73m2, x ± s)

66.86 ± 31.94

95.78 ± 17.69

2.443

0.020

UPE, [g/24 h, M(Q1,Q3)]

3.59(2.42,7.60)

4.05(3.27,4.99)

-0.405

0.686

Hematuria(number, %)

15(51.72)

2(25)

1.803

0.179

FIB (g/L,‾x ± s)

4.57 ± 1.16

4.10 ± 0.99

-1.033

0.309